FINAL lOGO.png
Rhodiola Rosea Supplement Market Size to Surpass US$ 38 billion by 2033 | Persistence Market Research
March 09, 2023 07:10 ET | Persistence Market Research
New York, March 09, 2023 (GLOBE NEWSWIRE) -- The Rhodiola Rosea Supplement Market revenues were estimated at US$ 14 billion in 2022 and are anticipated to grow at a CAGR of 9% from 2023 to 2033,...
TIP_link_300x300.jpg
Pulmonary Arterial Hypertension Market Worth ($10.88 Billion by 2028) Lead by Asia Pacific Region (6.5% CAGR) – Global Report by The Insight Partners
February 28, 2023 09:03 ET | The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Pulmonary Arterial Hypertension Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and...
Casana Name.png
Casana Appoints New CTO To Accelerate Technological Innovation in Remote Patient Monitoring
February 21, 2023 10:00 ET | Casana Care, Inc.
ROCHESTER, N.Y., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Casana, the leader in smart toilet heart health monitoring, today announced the appointment of medical device and regulatory veteran, Samir Zahine,...
Global Atrial Fibrillation Treatment Market
Outlook on the Atrial Fibrillation Treatment Global Market to 2027 - Rising Prevalence of Cardiovascular Diseases Drives Growth
December 22, 2022 06:38 ET | Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
TIP_link_300x300.jpg
$55+ Billion Stroke Management Market Size to Rise at a Stellar CAGR of 7.5% During (2022-2028) - COVID-19 Impact and Global Analysis by The Insight Partners
October 18, 2022 08:40 ET | The Insight Partners
New York, Oct. 18, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest market study on "Stroke Management Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19...
Logo.png
Hypertension Clinical Trials Pipeline Analysis: 90+ Companies are Working to Improve the Treatment Space | DelveInsight
October 03, 2022 13:00 ET | DelveInsight Business Research LLP
New York, USA, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Hypertension Clinical Trials Pipeline Analysis: 90+ Companies are Working to Improve the Treatment Space | DelveInsight As per a statement of World...
lexaria.jpg
Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution
August 11, 2022 08:30 ET | Lexaria Bioscience Corp.
NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “The Power of Science to Stop a Killer.” To...